- Home
- ASC vs AMLX Comparison
ASC vs AMLX Comparison
Compare ASC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- AMLX
- Stock Information
- Founded
- ASC 2010
- AMLX 2014
- Country
- ASC Bermuda
- AMLX United States
- Employees
- ASC 936
- AMLX N/A
- Industry
- ASC Marine Transportation
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- ASC Consumer Discretionary
- AMLX Health Care
- Exchange
- ASC Nasdaq
- AMLX Nasdaq
- Market Cap
- ASC 409.5M
- AMLX 459.1M
- IPO Year
- ASC 2013
- AMLX 2022
- Fundamental
- Price
- ASC $10.20
- AMLX $6.57
- Analyst Decision
- ASC Buy
- AMLX Strong Buy
- Analyst Count
- ASC 3
- AMLX 7
- Target Price
- ASC $13.67
- AMLX $11.14
- AVG Volume (30 Days)
- ASC 661.3K
- AMLX 1.8M
- Earning Date
- ASC 07-30-2025
- AMLX 08-07-2025
- Dividend Yield
- ASC 9.32%
- AMLX N/A
- EPS Growth
- ASC N/A
- AMLX N/A
- EPS
- ASC 2.30
- AMLX N/A
- Revenue
- ASC $373,479,000.00
- AMLX N/A
- Revenue This Year
- ASC N/A
- AMLX N/A
- Revenue Next Year
- ASC N/A
- AMLX N/A
- P/E Ratio
- ASC $4.23
- AMLX N/A
- Revenue Growth
- ASC N/A
- AMLX N/A
- 52 Week Low
- ASC $8.32
- AMLX $1.62
- 52 Week High
- ASC $22.72
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- ASC 56.33
- AMLX 67.73
- Support Level
- ASC $9.53
- AMLX $6.19
- Resistance Level
- ASC $10.21
- AMLX $6.59
- Average True Range (ATR)
- ASC 0.39
- AMLX 0.42
- MACD
- ASC -0.02
- AMLX 0.09
- Stochastic Oscillator
- ASC 65.04
- AMLX 86.13
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.